Basal Cell Carcinoma Review.

Hematol Oncol Clin North Am

High-Risk Skin Cancer Clinic, Dana Farber/Brigham and Women's Cancer Center, Mohs and Dermatologic Surgery Center, Brigham and Women's Faulkner Hospital, Harvard Medical School, 1153 Centre Street, Suite 4J, Jamaica Plain, MA 02130-3446, USA. Electronic address:

Published: February 2019

Basal cell carcinoma (BCC) is the most common malignancy and the incidence is rising. BCCs have low mortality but can cause significant morbidity primarily through local destruction. The pathogenesis is linked to the interplay between environmental and patient-derived characteristics. There are multiple therapeutic modalities, and appropriate selection requires knowledge of complications, cosmetic outcomes, and recurrence rates. This article reviews the epidemiology, staging, treatment, and prevention of BCC.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2018.09.004DOI Listing

Publication Analysis

Top Keywords

basal cell
8
cell carcinoma
8
carcinoma review
4
review basal
4
carcinoma bcc
4
bcc common
4
common malignancy
4
malignancy incidence
4
incidence rising
4
rising bccs
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!